Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients

Cell Host Microbe. 2017 Apr 12;21(4):530-537.e4. doi: 10.1016/j.chom.2017.03.003. Epub 2017 Mar 30.

Abstract

Despite the immune-reconstitution with antiretroviral therapy (ART), HIV-infected individuals remain highly susceptible to tuberculosis (TB) and have an enrichment of oral anaerobes in the lung. Products of bacterial anaerobic metabolism, like butyrate and other short-chain fatty acids (SCFAs), induce regulatory T cells (Tregs). We tested whether SCFAs contribute to poor TB control in a longitudinal cohort of ART-treated HIV-infected South Africans. Increase in serum SCFAs was associated with increased TB susceptibility. SCFAs inhibited IFN-γ and IL-17A production in peripheral blood mononuclear cells from HIV-infected ART-treated individuals in response to M. tuberculosis antigen stimulation. Pulmonary SCFAs correlated with increased oral anaerobes, such as Prevotella in the lung, and with M. tuberculosis antigen-induced Tregs. Metabolites from anaerobic bacterial fermentation may, therefore, increase TB susceptibility by suppressing IFN-γ and IL-17A production during the cellular immune response to M. tuberculosis.

Keywords: FoxP1; FoxP3; HIV; dysbiosis; lung; short-chain fatty acids; tuberculosis.

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Bacteria, Anaerobic / growth & development
  • Bacteria, Anaerobic / metabolism*
  • Disease Susceptibility*
  • Fatty Acids, Volatile / blood*
  • Fatty Acids, Volatile / metabolism
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Immunologic Factors / blood*
  • Immunologic Factors / metabolism
  • Interferon-gamma / metabolism
  • Interleukin-17 / metabolism
  • Leukocytes, Mononuclear / immunology
  • Longitudinal Studies
  • Lung / microbiology
  • Mycobacterium tuberculosis / immunology*
  • South Africa
  • T-Lymphocytes, Regulatory / immunology
  • Tuberculosis, Pulmonary / epidemiology
  • Tuberculosis, Pulmonary / immunology*

Substances

  • Anti-Retroviral Agents
  • Fatty Acids, Volatile
  • IL17A protein, human
  • Immunologic Factors
  • Interleukin-17
  • Interferon-gamma